Presentation is loading. Please wait.

Presentation is loading. Please wait.

Surgical Outcomes of Patients With Stage III Thymoma in the Japanese Nationwide Database  Yoshito Yamada, MD, PhD, Ichiro Yoshino, MD, PhD, Jun Nakajima,

Published byBudi Cahyadi Modified over 6 years ago

Similar presentations

Presentation on theme: "Surgical Outcomes of Patients With Stage III Thymoma in the Japanese Nationwide Database  Yoshito Yamada, MD, PhD, Ichiro Yoshino, MD, PhD, Jun Nakajima,"— Presentation transcript:

1 Surgical Outcomes of Patients With Stage III Thymoma in the Japanese Nationwide Database 
Yoshito Yamada, MD, PhD, Ichiro Yoshino, MD, PhD, Jun Nakajima, MD, PhD, Shinichiro Miyoshi, MD, PhD, Takamasa Ohnuki, MD, PhD, Makoto Suzuki, MD, PhD, Takeshi Nagayasu, MD, PhD, Akinori Iwasaki, MD, PhD, Meinoshin Okumura, MD, PhD  The Annals of Thoracic Surgery  Volume 100, Issue 3, Pages (September 2015) DOI: /j.athoracsur Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Clinical courses of patients in the study. The clinical course is demonstrated, with information regarding induction therapy and postoperative therapy. Ten-year overall survival (mean ± standard error of the mean) is also included. (C = chemo; OS = overall survival; R = radiotherapy.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Postoperative survival curves. (A) Overall survival; (B) disease-free survival. (Cum = cumulative.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Surgical Outcomes of Patients With Stage III Thymoma in the Japanese Nationwide Database  Yoshito Yamada, MD, PhD, Ichiro Yoshino, MD, PhD, Jun Nakajima,"

Similar presentations

Advantage of Induction Chemoradiotherapy for Lung Cancer in Securing Cancer-Free Bronchial Margin  Hiroki Sato, MD, Shinichi Toyooka, MD, PhD, Junichi.

Advantage of Induction Chemoradiotherapy for Lung Cancer in Securing Cancer-Free Bronchial Margin  Hiroki Sato, MD, Shinichi Toyooka, MD, PhD, Junichi.
Treating Constrictive Pericarditis in a Chinese Single-Center Study: A Five-Year Experience  Yiyun Lin, MD, Mi Zhou, MMS, Jian Xiao, MD, Bin Wang, MD,

Treating Constrictive Pericarditis in a Chinese Single-Center Study: A Five-Year Experience  Yiyun Lin, MD, Mi Zhou, MMS, Jian Xiao, MD, Bin Wang, MD,
Preoperative Serum Fibrinogen Level Predicts Postoperative Pulmonary Complications After Lung Cancer Resection  Suk-Won Song, MD, Hyun-Sung Lee, MD, Moon.

Preoperative Serum Fibrinogen Level Predicts Postoperative Pulmonary Complications After Lung Cancer Resection  Suk-Won Song, MD, Hyun-Sung Lee, MD, Moon.
Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F
Evaluation of the Reliability of Clinical Staging of T2 N0 Esophageal Cancer: A Review of The Society of Thoracic Surgeons Database  Traves D. Crabtree,

Evaluation of the Reliability of Clinical Staging of T2 N0 Esophageal Cancer: A Review of The Society of Thoracic Surgeons Database  Traves D. Crabtree,
B-Type Natriuretic Peptide as a Predictor of Postoperative Cardiopulmonary Complications in Elderly Patients Undergoing Pulmonary Resection for Lung Cancer 

B-Type Natriuretic Peptide as a Predictor of Postoperative Cardiopulmonary Complications in Elderly Patients Undergoing Pulmonary Resection for Lung Cancer 
Association of Perioperative Fluid Balance and Adverse Surgical Outcomes in Esophageal Cancer and Esophagogastric Junction Cancer  Shenhai Wei, MD, PhD,

Association of Perioperative Fluid Balance and Adverse Surgical Outcomes in Esophageal Cancer and Esophagogastric Junction Cancer  Shenhai Wei, MD, PhD,
Joshua E. Rosen, BASc, Hari B

Joshua E. Rosen, BASc, Hari B
The Effectiveness of Postoperative Radiotherapy in Patients With Completely Resected Thymoma: A Meta-Analysis  Dong Zhou, MD, Xu-Feng Deng, MD, Quan-Xing.

The Effectiveness of Postoperative Radiotherapy in Patients With Completely Resected Thymoma: A Meta-Analysis  Dong Zhou, MD, Xu-Feng Deng, MD, Quan-Xing.
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Off-pump Bilateral Skeletonized Internal Thoracic Artery Grafting in Elderly Patients  Takeshi Kinoshita, MD, Tohru Asai, MD, PhD, Tomoaki Suzuki, MD,

Off-pump Bilateral Skeletonized Internal Thoracic Artery Grafting in Elderly Patients  Takeshi Kinoshita, MD, Tohru Asai, MD, PhD, Tomoaki Suzuki, MD,
Hyde M. Russell, MD, Soraya L. Johnson, BS, Katherine C

Hyde M. Russell, MD, Soraya L. Johnson, BS, Katherine C
Effect of Perioperative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis  Takekazu Iwata, MD, PhD, Shigetoshi Yoshida,

Effect of Perioperative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis  Takekazu Iwata, MD, PhD, Shigetoshi Yoshida,
Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J
Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases
The Model for End-Stage Liver Disease (MELD) Predicts Early and Late Outcomes of Cardiovascular Operations in Patients With Liver Cirrhosis  Naoto Morimoto,

The Model for End-Stage Liver Disease (MELD) Predicts Early and Late Outcomes of Cardiovascular Operations in Patients With Liver Cirrhosis  Naoto Morimoto,
Clinical T2-T3N0M0 Esophageal Cancer: The Risk of Node Positive Disease  Brendon M. Stiles, MD, Farooq Mirza, MD, Anthony Coppolino, MD, Jeffrey L. Port,

Clinical T2-T3N0M0 Esophageal Cancer: The Risk of Node Positive Disease  Brendon M. Stiles, MD, Farooq Mirza, MD, Anthony Coppolino, MD, Jeffrey L. Port,
Ho Young Hwang, MD, Jun Sung Kim, MD, Ki-Bong Kim, MD, PhD 

Ho Young Hwang, MD, Jun Sung Kim, MD, Ki-Bong Kim, MD, PhD 
Adding Radiotherapy to Adjuvant Chemotherapy Does Not Improve Survival of Patients With N2 Lung Cancer  Justin A. Drake, MD, David C. Portnoy, MD, Kurt.

Adding Radiotherapy to Adjuvant Chemotherapy Does Not Improve Survival of Patients With N2 Lung Cancer  Justin A. Drake, MD, David C. Portnoy, MD, Kurt.
Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H

Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H

Similar presentations

Ads by Google